High-level levodopa therapy in Parkinson's disease: five years later
- PMID: 4463526
Item in Clipboard
High-level levodopa therapy in Parkinson's disease: five years later
Trans Am Neurol Assoc.
1974.
No abstract available
Similar articles
-
Parkinson's disease and long-term levodopa therapy.Adv Neurol. 1987;45:463-7. Adv Neurol. 1987. PMID: 3103389 No abstract available.
-
[Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years].Rinsho Shinkeigaku. 1987 Nov;27(11):1419-22. Rinsho Shinkeigaku. 1987. PMID: 3447802 Japanese. No abstract available.
-
Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.Arch Neurol. 2009 May;66(5):563-70. doi: 10.1001/archneur.66.1.nct90001. Arch Neurol. 2009. PMID: 19433655 Clinical Trial.
-
Continuous dopaminergic stimulation for Parkinson's disease: facts and fancy.Funct Neurol. 1988 Oct-Dec;3(4):413-27. Funct Neurol. 1988. PMID: 3072277 Review. No abstract available.
-
Treatment of Parkinson's disease: levodopa as the first choice.J Neurol. 2002 Sep;249 Suppl 2:II19-24. doi: 10.1007/s00415-002-1204-4. J Neurol. 2002. PMID: 12375059 Review.
Cited by
-
DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.Pharmgenomics Pers Med. 2010;3:61-78. doi: 10.2147/pgpm.s6800. Epub 2010 May 21. Pharmgenomics Pers Med. 2010. PMID: 23226043 Free PMC article.
-
Orquestic regulation of neurotransmitters on reward-seeking behavior.Int Arch Med. 2014 Jun 16;7:29. doi: 10.1186/1755-7682-7-29. eCollection 2014. Int Arch Med. 2014. PMID: 25061480 Free PMC article. Review.
-
Dopaminergic reward system: a short integrative review.Int Arch Med. 2010 Oct 6;3:24. doi: 10.1186/1755-7682-3-24. Int Arch Med. 2010. PMID: 20925949 Free PMC article.